NASDAQ:ANGO
AngioDynamics Stock News
$5.87
+0.170 (+2.98%)
At Close: Mar 28, 2024
AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note
07:32pm, Monday, 11'th Dec 2023
AngioDynamics (ANGO) closed at $6.91 in the latest trading session, marking a -0.72% move from the prior day.
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
04:01pm, Thursday, 07'th Dec 2023
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expand
AngioDynamics (ANGO) Falls More Steeply Than Broader Market: What Investors Need to Know
07:32pm, Monday, 04'th Dec 2023
AngioDynamics (ANGO) closed the most recent trading day at $6.77, moving -1.31% from the previous trading session.
AngioDynamics (ANGO) Stock Slides as Market Rises: Facts to Know Before You Trade
07:32pm, Tuesday, 28'th Nov 2023
In the most recent trading session, AngioDynamics (ANGO) closed at $6.74, indicating a -0.15% shift from the previous trading day.
AngioDynamics (ANGO) Outperforms Broader Market: What You Need to Know
07:32pm, Wednesday, 22'nd Nov 2023
AngioDynamics (ANGO) closed the most recent trading day at $6.85, moving +1.33% from the previous trading session.
AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note
07:32pm, Thursday, 16'th Nov 2023
In the latest trading session, AngioDynamics (ANGO) closed at $6.86, marking a -1.15% move from the previous day.
AngioDynamics (ANGO) Advances But Underperforms Market: Key Facts
07:32pm, Friday, 10'th Nov 2023
In the closing of the recent trading day, AngioDynamics (ANGO) stood at $6.21, denoting a +0.65% change from the preceding trading day.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
10:32am, Friday, 06'th Oct 2023
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates
12:02pm, Thursday, 05'th Oct 2023
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2024.
Why Angiodynamics Stock Sank Today
06:15pm, Wednesday, 04'th Oct 2023
The medical device and technology specialist unveiled its latest set of quarterly results. Its bottom line was in the red and only marginally beat estimates.
AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates
09:46am, Wednesday, 04'th Oct 2023
AngioDynamics (ANGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.06 per share a year ago.
Why AngioDynamics Stock Popped on Monday
01:21pm, Monday, 25'th Sep 2023
An investment bank initiated coverage of the stock with a buy rating this morning. The banker believes AngioDynamics stock could nearly triple over the next year.
AngioDynamics: Enormous Effort Required In Fiscal '24 To Reverse The Equity Picture
03:52am, Sunday, 17'th Sep 2023
AngioDynamics, Inc. posted mixed results in its FY'23 reports, with strong growth in its Med Tech division. The company's focus going forward will be on its Med Tech segment, which has shown high grow
AngioDynamics (ANGO) Flat As Market Sinks: What You Should Know
07:17pm, Thursday, 17'th Aug 2023
AngioDynamics (ANGO) closed at $8.58 in the latest trading session, marking no change from the prior day.
AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment
12:29pm, Wednesday, 16'th Aug 2023
The FDA's grant of the Breakthrough Device designation for AngioDynamics' (ANGO) AngioVac is likely to remove thrombus and embolic material and minimize blood loss via blood recirculation.